L455-0332 Screening compound: 5-[4-(3-chlorophenyl)piperazine-1-carbonyl]-1-[(3-methoxyphenyl)methyl]-1H-1,2,3-benzotriazole

L455-0332 Screening compound: 5-[4-(3-chlorophenyl)piperazine-1-carbonyl]-1-[(3-methoxyphenyl)methyl]-1H-1,2,3-benzotriazole
L455-0332 Screening compound: 5-[4-(3-chlorophenyl)piperazine-1-carbonyl]-1-[(3-methoxyphenyl)methyl]-1H-1,2,3-benzotriazole alternative view

Chemical Structure Depiction of ChemDiv screening compound L455-0332
5-[4-(3-chlorophenyl)piperazine-1-carbonyl]-1-[(3-methoxyphenyl)methyl]-1H-1,2,3-benzotriazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L455-0332

Molecular Formula

C25H24ClN5O2 (C25 H24 ClN5 O2)

Compound Name

5-[4-(3-chlorophenyl)piperazine-1-carbonyl]-1-[(3-methoxyphenyl)methyl]-1H-1,2,3-benzotriazole

IUPAC name

5-[4-(3-chlorophenyl)piperazine-1-carbonyl]-1-[(3-methoxyphenyl)methyl]-1H-123-benzotriazole

SMILES

COc1cccc(Cn2nnc3c2ccc(C(N(CC2)CCN2c2cccc(Cl)c2)=O)c3)c1

InChI

InChI=1S/C25H24ClN5O2/c1-33-22-7-2-4-18(14-22)17-31-24-9-8-19(15-23(24)27-28-31)25(32)30-12-10-29(11-13-30)21-6-3-5-20(26)16-21/h2-9,14-16H,10-13,17H2,1H3

InChI Key

PUHDCWMGRMECPC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27253690

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.95

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.668

Distribution Coefficient, logD

3.668

Water Solubility, LogSw

-4.06

Polar Surface Area

53.117

Acid Dissociation Constant (pKa)

24.75

Base Dissociation Constant (pKb)

1.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

L455-0332 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with L455-0332 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L455-0332?
Check Price and Availability of L455-0332, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L455-0332 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L455-0332
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L455-0332
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L455-0332 available by request